Endo
$0.29
24H
Market Cap
Volume
Supply
Price Chart
About Endo - ENDP
Endo International plc is a global pharmaceutical company that develops, manufactures, and distributes generic and branded pharmaceuticals, with a focus on pain management, urology, orthopedics, and endocrinology. The company is incorporated in Ireland and has its U.S. headquarters in Malvern, Pennsylvania.
What are Endo's core values and mission statement?
Endo International plc is a pharmaceutical company that emphasizes a commitment to quality, integrity, and collaboration in its core values. Their mission focuses on improving patients' lives by developing and delivering high-quality, cost-effective generic and branded pharmaceuticals.
Who founded Endo and when?
Endo International plc was founded in 1997 by Carol Ammon and Alfred Altomari.
Who leads Endo?
Endo International plc is typically led by a Chief Executive Officer (CEO); however, the current individual in that position can change due to company decisions or board changes. To obtain the most recent information on the leadership, one should check the latest company reports or the official Endo International website.
Where is Endo located, and what is its base country?
Endo International plc is headquartered in Dublin, Ireland, and its base country is Ireland.
On which exchanges is Endo traded?
Endo International plc is listed on the NASDAQ under the ticker symbol ENDP.
Historical data
Endo (ENDP) Price Live Data
The live price of Endo (ENDP) is $0.29, with a trading volume of 39,155,658 in the last 24 hours. Wrapstocks updates the ENDP price in real-time. Endo is up 0% in the last 24 hours. The company has a live market cap of $-1.00 and a supply of -3 ENDP stocks.
Endo (ENDP) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 16 hours and 16 minutes.
